Crohns & Colitis 360

Scope & Guideline

Connecting researchers to revolutionize gastrointestinal health.

Introduction

Welcome to the Crohns & Colitis 360 information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Crohns & Colitis 360, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN-
PublisherOXFORD UNIV PRESS
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationCROHNS COLITIS 360 / Crohns Colitis 360
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND

Aims and Scopes

The journal 'Crohns & Colitis 360' focuses on advancing the understanding and management of inflammatory bowel disease (IBD), particularly Crohn's disease and ulcerative colitis. Its research encompasses a variety of methodologies, including clinical studies, systematic reviews, and qualitative research, aimed at improving patient outcomes through evidence-based practices.
  1. Clinical Management of IBD:
    Research aimed at optimizing treatment pathways, medication adherence, and clinical decision-making in the management of Crohn's disease and ulcerative colitis.
  2. Patient-Centric Research:
    Studies focusing on patient experiences, perspectives, and quality of life related to IBD, emphasizing the importance of patient engagement in treatment decisions.
  3. Innovative Therapeutics:
    Exploration of new therapeutic agents, including biologics and small molecules, and their efficacy, safety, and long-term outcomes in IBD treatment.
  4. Epidemiological and Health Economic Studies:
    Research investigating the prevalence, healthcare costs, and economic burden of IBD, providing insights into the broader impact of these diseases on healthcare systems.
  5. Use of Technology in IBD Management:
    Utilization of artificial intelligence, machine learning, and telehealth to enhance diagnostic accuracy, treatment adherence, and patient monitoring.
  6. Nutritional and Dietary Interventions:
    Exploration of the role of diet and nutrition in managing IBD symptoms and improving patient outcomes, including the effectiveness of dietary therapies.
Recent publications in 'Crohns & Colitis 360' indicate several emerging and trending themes that reflect the evolving landscape of IBD research. This section outlines these key areas of focus that are gaining traction.
  1. Real-World Evidence and Patient Outcomes:
    There is a growing emphasis on real-world studies that assess treatment effectiveness and patient-reported outcomes, highlighting the importance of understanding therapy impacts in everyday clinical settings.
  2. Telehealth and Remote Monitoring:
    Research exploring telehealth solutions and remote patient monitoring technologies is on the rise, especially in the context of increasing patient needs for accessible care and management during the COVID-19 pandemic.
  3. Psychosocial Factors in IBD:
    Emerging studies focus on the psychosocial aspects of living with IBD, including the impact of mental health on disease management and the importance of addressing psychological comorbidities.
  4. Diversity and Health Disparities:
    There is an increasing awareness and study of racial, ethnic, and geographic disparities in IBD care and outcomes, emphasizing the need for equitable healthcare access.
  5. Dietary Interventions and Personalized Nutrition:
    Research into dietary therapies and their role in managing IBD symptoms is expanding, with a focus on personalized nutritional approaches tailored to individual patient needs.

Declining or Waning

While many themes continue to thrive within 'Crohns & Colitis 360', certain areas of research appear to be waning in prominence. This section highlights those themes that are increasingly less represented in recent publications.
  1. Traditional Pharmacotherapy:
    Research focused exclusively on conventional medications for IBD, such as corticosteroids and thiopurines, seems to be declining as newer therapies gain attention.
  2. Surgical Interventions:
    The volume of studies addressing surgical management of IBD, including colectomies and resections, is decreasing, possibly due to a shift towards medical management and minimally invasive techniques.
  3. Basic Science and Mechanistic Studies:
    There is less emphasis on basic science research exploring the underlying mechanisms of IBD, as the journal increasingly prioritizes clinical and translational research.
  4. Single-Center Studies:
    The prevalence of single-center studies is diminishing in favor of multicenter collaborations that provide broader data and insights into IBD management.
  5. Conventional Epidemiological Studies:
    Traditional epidemiological research focusing solely on demographic trends in IBD without integrating patient-reported outcomes or economic evaluations appears to be less frequent.

Similar Journals

GUT

Leading the Way in Digestive Health Discourse
Publisher: BMJ PUBLISHING GROUPISSN: 0017-5749Frequency: 12 issues/year

GUT is a premier journal in the field of gastroenterology, published by the esteemed BMJ Publishing Group. With a rich history dating back to 1960 and an impressive convergence of research expected to continue through 2024, GUT has established itself as a cornerstone of academic discourse in the gastrointestinal sciences. The journal boasts a remarkable impact factor, positioning it in the Q1 category for gastroenterology with an outstanding rank of #3 out of 167 in its Scopus ranking, reflecting its 98th percentile status among peers. Although it does not currently offer open access options, GUT remains dedicated to disseminating high-quality research, reviews, and clinical studies that advance the understanding of digestive health. Published in the United Kingdom, GUT serves as an essential resource for researchers, clinicians, and students aiming to stay at the forefront of innovations and developments in the field.

Clinical and Experimental Gastroenterology

Fostering knowledge and innovation in gastrointestinal research.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-7023Frequency: 1 issue/year

Clinical and Experimental Gastroenterology is a prestigious Open Access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of gastroenterology through rigorous research and innovative insights. With its ISSN 1178-7023, the journal has established a significant presence since its inception in 2008 and has been actively contributing to the academic landscape from New Zealand. The journal has attained a commendable Q2 rank in the Gastroenterology category as of 2023, placing it in the upper-tier percentile of similar journals. It currently ranks #57 out of 167 in the Scopus database, highlighting its relevance and impact in the field at the 66th percentile. Encompassing a wide range of topics within gastroenterology, the journal aims to foster discussion and disseminate findings that enhance clinical practices and patient care. Researchers, healthcare professionals, and students alike will find this journal an invaluable resource for cutting-edge research and developments in gastrointestinal health.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Unveiling Breakthroughs in Gastrointestinal Therapeutics
Publisher: WILEYISSN: 0269-2813Frequency: 24 issues/year

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, published by Wiley, is a premier scholarly journal in the fields of gastroenterology, hepatology, and pharmacology. With an impressive impact factor and ranking in the top quartile (Q1) of its classifications, the journal is recognized for its rigorous peer-reviewed research and comprehensive reviews, aiming to advance the understanding of therapeutic interventions in gastrointestinal and liver diseases. Since its inception in 1987, it has become an essential resource for researchers, healthcare professionals, and students alike, fostering scientific dialogue and innovation. With a Scopus rank placing it in the 97th percentile for pharmacology and 96th for gastroenterology, it is dedicated to publishing the most significant and impactful findings in the field. ALIMENTARY PHARMACOLOGY & THERAPEUTICS thus plays a vital role in shaping the future of medical treatments and interventions in gastrointestinal health.

Therapeutic Advances in Gastroenterology

Championing the future of gastroenterology.
Publisher: SAGE PUBLICATIONS LTDISSN: 1756-283XFrequency: 1 issue/year

Therapeutic Advances in Gastroenterology, published by SAGE Publications Ltd, is a premier open access journal dedicated to the advancement of knowledge in the field of gastroenterology. Since its inception in 2008 and its transition to open access in 2018, the journal has consistently provided high-quality peer-reviewed research articles, review papers, and clinical studies that address the latest therapeutic advancements and challenges in gastrointestinal medicine. With an impressive impact factor and a 2023 Scopus ranking placing it in the Q1 quartile of gastroenterology journals, it stands as a leading platform for researchers, clinicians, and healthcare professionals. The journal’s commitment to disseminating impactful research has positioned it at the forefront of academic discourse, offering a vital resource for those devoted to improving patient outcomes in digestive health. The United Kingdom-based journal invites submissions that contribute to the understanding and treatment of gastrointestinal disorders, ensuring that cutting-edge findings reach a global audience.

Intestinal Research

Championing Open Access for Intestinal Research Excellence
Publisher: KOREAN ASSOC STUDY INTESTINAL DISEASESISSN: 1598-9100Frequency: 4 issues/year

Intestinal Research is an influential open-access journal dedicated to advancing knowledge in the field of gastroenterology. Published by the Korean Association for the Study of Intestinal Diseases, this journal has been providing valuable insights into intestinal health since its inception in 2003. With an impressive impact factor and a current ranking of Q2 in the gastroenterology category, it is recognized among the top journals in its field, achieving a remarkable 82nd percentile in Scopus rankings. Based in South Korea, the journal's mission is to facilitate research and discussions on intestinal diseases, pathophysiology, innovative treatments, and advancements in care practices. By offering open access, Intestinal Research ensures that critical findings are readily available to researchers, healthcare professionals, and students alike, fostering global collaboration and sharing of knowledge. The journal accepts contributions that reflect the latest developments and foster deep understanding within the intestinal disease research community.

Gastrointestinal Disorders

Transforming Gastroenterology Through Collaborative Scholarship
Publisher: MDPIISSN: Frequency: 4 issues/year

Gastrointestinal Disorders is a prominent open-access journal published by MDPI, based in Switzerland, that focuses on the latest research and innovations in the fields of gastroenterology, hepatology, and immunology. Since its inception in 2019, the journal has provided a vital platform for researchers and professionals to disseminate their findings, engaging with a global audience keen on advancing knowledge in gastrointestinal health. With a dedicated commitment to high-quality, peer-reviewed articles, Gastrointestinal Disorders has gained recognition in 2023, achieving Q3 status in gastroenterology and notable rankings in several other categories, including a respectable position in the quartiles for hepatology, immunology, and oncology. Despite its recent establishment, the journal has quickly become a valuable resource, facilitating open access to critical insights in the study of gastrointestinal diseases and their management, ensuring that emerging research is readily available to inform clinical practice and educate future professionals.

Gastroenterologia y Hepatologia

Bridging research and practice in gastroenterology and hepatology.
Publisher: ELSEVIER ESPANA SLUISSN: 0210-5705Frequency: 10 issues/year

Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.

Journal of Gastrointestinal and Liver Diseases

Advancing Knowledge in Gastrointestinal and Liver Health
Publisher: MEDICAL UNIV PRESSISSN: 1841-8724Frequency: 4 issues/year

The Journal of Gastrointestinal and Liver Diseases, published by MEDICAL UNIV PRESS in Romania, serves as a pivotal platform for the dissemination of significant research in the fields of gastroenterology and hepatology. Established in 2006, this journal has evolved over the years, currently holding a Q3 rank in Gastroenterology and a Q2 rank in Medicine (miscellaneous), reflecting its commitment to high-quality scholarship and impactful contributions to medical science.

With an ISSN of 1841-8724 and an E-ISSN of 1842-1121, the journal engages a diverse readership of researchers, clinicians, and students passionate about advancing knowledge in gastrointestinal and liver health. While it currently does not operate under an open access model, the journal remains a vital resource for those seeking to stay updated on the latest developments and emerging trends in the field. As it converges towards a broader impact, projected through its coverage until 2024, the Journal of Gastrointestinal and Liver Diseases continues to contribute to the academic landscape, encouraging innovation and comprehensive understanding in digestive health.

Pediatric Gastroenterology Hepatology & Nutrition

Exploring the frontiers of gastroenterology and nutrition in children.
Publisher: KOREAN SOC PEDIATRIC GASTROENTEROLOGY & NUTRITIONISSN: 2234-8646Frequency: 6 issues/year

Pediatric Gastroenterology Hepatology & Nutrition is a pivotal academic journal published by the Korean Society of Pediatric Gastroenterology & Nutrition, focusing on the critical fields of pediatric gastroenterology, hepatology, and nutrition. Located in South Korea, this journal aims to disseminate high-quality research, review articles, and clinical studies to advance knowledge and practice in the care of children with gastrointestinal and nutritional disorders. With a Converged Years span from 2012 to 2024 and categorized in the Q2 and Q3 quartiles in 2023 across multiple related fields, the journal holds a significant position within the academic community, reflecting its impactful contribution to the discipline. Although currently not open access, the journal ensures that content is accessible to a broad audience through various institutional subscriptions. The journal appeals to researchers, healthcare professionals, and students alike, providing an essential platform for the exchange of innovative ideas and research findings aimed at improving pediatric patient care.

JGH Open

Elevating Research, Enhancing Lives
Publisher: WILEYISSN: 2397-9070Frequency: 1 issue/year

JGH Open is a prominent open-access journal dedicated to advancing knowledge in the fields of Gastroenterology and Hepatology, published by WILEY. Since its inception in 2017, the journal has served as a crucial platform for researchers, professionals, and students to disseminate innovative research findings and clinical insights. With an impact factor and Scopus rankings reflecting its steady growth—ranking in the 3rd quartile for both Gastroenterology (Q3) and Hepatology (Q3)—JGH Open is positioned within the competitive landscape of medicine. Its commitment to open access enhances the visibility and accessibility of high-quality research, ensuring that significant advancements in understanding diseases of the gastrointestinal tract and liver reach a broad audience. With a focus on collaboration and dissemination of knowledge, JGH Open aims to contribute to the global discourse and improve outcomes in gastrointestinal health.